pi-0824
Vaccineexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2003 (NCT00063752)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Desmoglein-3Immunity, active
DSG3 immunity, active
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- NCATSUG5KU6AQ0Z ↗
- ChEMBLCHEMBL4297810 ↗
Also known as
- pi-0824
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00063752 | Phase 1 | Jul 1, 2003 | Peptimmune |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Peptimmune | For profit | 1 | 1 | 1 | 2003 |
1 organizations
Page 1 / 1